Patents Assigned to Salvia Sciences, Inc.
  • Ester prodrugs of prostratin and related phorbol compounds
    Patent number: 8431612
    Abstract: The present disclosure provides analogs and derivatives of phorbol compounds for the treatment of viral infections, neoplastic diseases, inflammatory reactions, and use as analgesics.
    Type: Grant
    Filed: June 21, 2011
    Date of Patent: April 30, 2013
    Assignee: Salvia Sciences, Inc.
    Inventors: Rensheng Xu, Weiman Zhao, Chun Jiang
  • Ester Prodrugs of Prostratin and Related Phorbol Compounds
    Publication number: 20110251421
    Abstract: The present disclosure provides analogs and derivatives of phorbol compounds for the treatment of viral infections, neoplastic diseases, inflammatory reactions, and use as analgesics.
    Type: Application
    Filed: June 21, 2011
    Publication date: October 13, 2011
    Applicant: SALVIA SCIENCES, INC.
    Inventors: Rensheng Xu, Weimin Zhao, Chun Jiang
  • Ester prodrugs of prostratin and related phorbol compounds
    Patent number: 8022103
    Abstract: Ester prodrugs of phorbol compounds for the treatment of viral infections, neoplastic diseases, inflammatory reactions, and use as analgesics, wherein the phorbol compounds are derivatized with a -x-o-c(o)-R? group linked to the 6-carbon of the phorbol residue.
    Type: Grant
    Filed: July 13, 2006
    Date of Patent: September 20, 2011
    Assignee: Salvia Sciences, Inc.
    Inventors: Rensheng Xu, Weimin Zhao, Chun Jiang
  • ESTER PRODRUGS OF PROSTRATIN AND RELATED PHORBOL COMPOUNDS
    Publication number: 20090163587
    Abstract: Ester prodrugs of phorbol compounds for the treatment of viral infections, neoplastic diseases, inflammatory reactions, and use as analgesics, wherein the phorbol compounds are derivatized with a -x-o-c(o)-R? group linked to the 6-carbon of the phorbol residue.
    Type: Application
    Filed: July 13, 2006
    Publication date: June 25, 2009
    Applicant: Salvia Sciences, Inc.
    Inventors: Rensheng Xu, Weimin Zhao, Chun Jiang